Scientific Board


Prof. Oliver Planz, Ph.D.
Universität D-Tübingen,
Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.

 

Prof. Stephan Ludwig, Ph.D.
Universität D-Münster
Co-inventor of the technology, globally renowned expert in influenza virus-cell interactions. Over 150 scientific publications and more than 10 patents.

 

StephanPleschka

Prof. Stephan Pleschka, Ph.D.
Universität D-Gießen
Co-inventor of the technology. Expert in replication, infection and cell-virus interactions of the influenza virus. Advisor to biotech companies.